SG11201706819RA - Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease - Google Patents
Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye diseaseInfo
- Publication number
- SG11201706819RA SG11201706819RA SG11201706819RA SG11201706819RA SG11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA
- Authority
- SG
- Singapore
- Prior art keywords
- prophylaxis
- treatment
- synthetic peptide
- dry eye
- eye disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2015/073257 WO2016134498A1 (en) | 2015-02-25 | 2015-02-25 | Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201706819RA true SG11201706819RA (en) | 2017-09-28 |
Family
ID=56787800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201706819RA SG11201706819RA (en) | 2015-02-25 | 2015-02-25 | Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10307456B2 (en) |
| EP (1) | EP3262060B1 (en) |
| JP (1) | JP6503085B2 (en) |
| KR (1) | KR102023827B1 (en) |
| CN (1) | CN107428805B (en) |
| AU (1) | AU2015384099B2 (en) |
| CA (1) | CA2977562C (en) |
| ES (1) | ES2772772T3 (en) |
| NZ (1) | NZ734845A (en) |
| SG (1) | SG11201706819RA (en) |
| WO (1) | WO2016134498A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10463710B2 (en) * | 2015-04-27 | 2019-11-05 | Mackay Memorial Hospital | Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders |
| CN108785251B (en) * | 2018-01-23 | 2020-11-24 | 盛元医药广州有限公司 | Medicinal composition for eyes and preparation method and application thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3191038B2 (en) * | 1996-06-26 | 2001-07-23 | 輝夫 西田 | Ophthalmic pharmaceutical composition |
| US7834146B2 (en) * | 2000-05-08 | 2010-11-16 | Monsanto Technology Llc | Recombinant polypeptides associated with plants |
| TWI305778B (en) * | 2001-12-03 | 2009-02-01 | Nishida Teruo | Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use |
| US7381707B2 (en) * | 2005-06-30 | 2008-06-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment of dry eye |
| US9096689B2 (en) * | 2007-11-07 | 2015-08-04 | Northwestern University | Methods and compositions for inhibiting angiogenesis |
| CN102100693A (en) * | 2009-12-16 | 2011-06-22 | 沈阳兴齐制药有限公司 | Artificial tears including carnosine and preparation method thereof |
| CN101745098A (en) * | 2010-01-26 | 2010-06-23 | 暨南大学 | Application of nerve polypeptide PACAP38 in the preparation of eye disease curing, injury repair or reproduction drugs |
| CN101947307B (en) * | 2010-08-19 | 2012-08-15 | 中山大学中山眼科中心 | Applications of human placenta peptide in preparing drugs for treating dry eye syndrome and other ocular surface diseases |
| KR20140099526A (en) * | 2011-11-30 | 2014-08-12 | 자이겐 인플라메이션 리미티드 | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of dry eye syndrome |
| US10463710B2 (en) * | 2015-04-27 | 2019-11-05 | Mackay Memorial Hospital | Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders |
-
2015
- 2015-02-25 CA CA2977562A patent/CA2977562C/en active Active
- 2015-02-25 JP JP2017545536A patent/JP6503085B2/en active Active
- 2015-02-25 CN CN201580076909.8A patent/CN107428805B/en active Active
- 2015-02-25 NZ NZ734845A patent/NZ734845A/en unknown
- 2015-02-25 US US15/552,529 patent/US10307456B2/en active Active
- 2015-02-25 SG SG11201706819RA patent/SG11201706819RA/en unknown
- 2015-02-25 AU AU2015384099A patent/AU2015384099B2/en active Active
- 2015-02-25 KR KR1020177026074A patent/KR102023827B1/en active IP Right Grant
- 2015-02-25 ES ES15882936T patent/ES2772772T3/en active Active
- 2015-02-25 WO PCT/CN2015/073257 patent/WO2016134498A1/en active Application Filing
- 2015-02-25 EP EP15882936.6A patent/EP3262060B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2772772T3 (en) | 2020-07-08 |
| KR102023827B1 (en) | 2019-09-23 |
| JP2018508514A (en) | 2018-03-29 |
| WO2016134498A1 (en) | 2016-09-01 |
| EP3262060A4 (en) | 2018-09-05 |
| EP3262060B1 (en) | 2019-12-25 |
| CN107428805A (en) | 2017-12-01 |
| JP6503085B2 (en) | 2019-04-17 |
| US10307456B2 (en) | 2019-06-04 |
| NZ734845A (en) | 2018-08-31 |
| AU2015384099B2 (en) | 2018-04-05 |
| CA2977562A1 (en) | 2016-09-01 |
| CA2977562C (en) | 2019-12-03 |
| KR20170126468A (en) | 2017-11-17 |
| US20180339010A1 (en) | 2018-11-29 |
| CN107428805B (en) | 2021-01-08 |
| AU2015384099A1 (en) | 2017-09-14 |
| EP3262060A1 (en) | 2018-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251257A1 (en) | Use of exosomes for the treatment of disease | |
| AU201810677S (en) | Skin treatment article | |
| AU201714140S (en) | Skin treatment article | |
| AU201714143S (en) | Skin treatment article | |
| AU201810686S (en) | Skin treatment article | |
| IL254142B (en) | Tradipitant for use in the treatment of a tradipitant-responsive disease or condition | |
| IL253872A0 (en) | Non-natural semaphorins 3 and their medical use | |
| AU201810683S (en) | Skin treatment article | |
| AU201810685S (en) | Skin treatment article | |
| AU201714141S (en) | Skin treatment article | |
| PL3277280T3 (en) | Isomyosmine for use in the treatment of autoimmune diseases | |
| ZA201704726B (en) | Peptides and their use in the treatment of skin | |
| EP3463344A4 (en) | Treatment of dry eye disease with parasympathetic and anti-sympathetic agents | |
| AU201810687S (en) | Skin treatment article | |
| AU201810689S (en) | Skin treatment article | |
| LT3722291T (en) | Indolinone compounds and their use in the treatment of fibrotic diseases | |
| IL281585B (en) | Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof | |
| HK1243719A1 (en) | Short synthetic peptide for treating diseases and/or conditions related to angiogenesis | |
| HK1257585A1 (en) | Medicine for preventing and treating skin fibrosis and use of the medicine | |
| GB201504387D0 (en) | Materials and methods for the treatment of vascular disease | |
| GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
| SG11201706819RA (en) | Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease | |
| AU201810676S (en) | Skin treatment article | |
| SG11201703624PA (en) | Compounds for the diagnosis or treatment of disorders associated with protein or peptide oligomers | |
| EP3110453A4 (en) | Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions |